Total Payments
$62,885
2024 Payments
$1,189
Companies
33
Transactions
717
Medicare Patients
9,912
Medicare Billing
$462,895
Payment Breakdown by Category
Other$30,090 (47.8%)
Consulting$16,550 (26.3%)
Food & Beverage$14,564 (23.2%)
Travel$1,489 (2.4%)
Education$191.86 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $30,090 | 17 | 47.8% |
| Consulting Fee | $16,550 | 8 | 26.3% |
| Food and Beverage | $14,564 | 677 | 23.2% |
| Travel and Lodging | $1,489 | 8 | 2.4% |
| Education | $191.86 | 7 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $24,738 | 44 | $0 (2018) |
| ARALEZ PHARMACEUTICALS US INC. | $16,081 | 26 | $0 (2018) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $8,337 | 42 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,958 | 131 | $0 (2024) |
| ABIOMED | $1,896 | 38 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,766 | 78 | $0 (2024) |
| Amgen Inc. | $1,098 | 59 | $0 (2024) |
| Abbott Laboratories | $990.32 | 8 | $0 (2024) |
| Boston Scientific Corporation | $929.10 | 35 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $699.82 | 59 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,189 | 58 | Philips North America LLC ($221.30) |
| 2023 | $3,420 | 69 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($1,634) |
| 2022 | $6,518 | 111 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($3,273) |
| 2021 | $4,782 | 84 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($3,204) |
| 2020 | $1,061 | 57 | AstraZeneca Pharmaceuticals LP ($227.57) |
| 2019 | $1,033 | 46 | AstraZeneca Pharmaceuticals LP ($291.77) |
| 2018 | $19,288 | 136 | Gilead Sciences, Inc. ($11,267) |
| 2017 | $25,594 | 156 | Gilead Sciences Inc ($13,471) |
All Payment Transactions
717 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $7.37 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $7.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | Abbott Laboratories | AMPLATZER TALISMAN (Device) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Structural Heart | ||||||
| 11/26/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $4.74 | General |
| Category: Renal Denervation System | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $7.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.43 | General |
| Category: Cardiovascular | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: DIABETES | ||||||
| 10/14/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $10.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/30/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.57 | General |
| Category: Cardiovascular | ||||||
| 09/24/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $22.71 | General |
| 09/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Cardiology | ||||||
| 09/11/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Cardiology | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $2.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/19/2024 | Vital Connect, Inc | VITALPATCH RTM (Device) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: CARDIOLOGY | ||||||
| 08/01/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: Cardiology | ||||||
| 07/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/12/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $40.09 | General |
| Category: Medical Device | ||||||
| 07/01/2024 | CARDIVA MEDICAL, INC. | SAVVYWIRE (Device) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: DEVICES | ||||||
| 06/28/2024 | Philips North America LLC | (BR0) Coronary Atherectomy (Device) | Food and Beverage | Cash or cash equivalent | $18.95 | General |
| Category: Medical Device | ||||||
| 06/26/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $74.56 | General |
| Category: Medical Device | ||||||
| 06/24/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $74.56 | General |
| Category: Medical Device | ||||||
| 06/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,960 | 2,116 | $431,153 | $91,052 |
| 2022 | 28 | 2,329 | 2,623 | $468,258 | $111,023 |
| 2021 | 29 | 2,741 | 3,046 | $497,981 | $121,555 |
| 2020 | 32 | 2,882 | 3,133 | $565,815 | $139,265 |
Total Patients
9,912
Total Services
10,918
Medicare Billing
$462,895
Procedure Codes
130
All Medicare Procedures & Services
130 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 227 | 299 | $87,009 | $19,091 | 21.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 78 | 79 | $66,913 | $14,487 | 21.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 258 | 258 | $50,310 | $12,433 | 24.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 191 | 191 | $43,719 | $9,575 | 21.9% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 19 | 23 | $34,753 | $9,028 | 26.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 30 | $16,860 | $3,956 | 23.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 547 | 596 | $23,434 | $3,559 | 15.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 24 | 32 | $9,056 | $2,894 | 32.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 44 | 44 | $11,792 | $2,263 | 19.2% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 11 | 13 | $12,389 | $2,229 | 18.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $9,196 | $1,615 | 17.6% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 64 | 64 | $8,384 | $1,511 | 18.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 21 | 21 | $5,628 | $1,218 | 21.6% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 109 | 116 | $15,080 | $1,087 | 7.2% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 13 | 15 | $7,365 | $1,057 | 14.3% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 11 | 12 | $5,652 | $809.10 | 14.3% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 44 | 44 | $4,312 | $647.97 | 15.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $2,069 | $513.58 | 24.8% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 26 | 34 | $2,040 | $485.70 | 23.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 20 | 20 | $1,600 | $464.64 | 29.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 43 | 43 | $2,795 | $432.18 | 15.5% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 24 | 24 | $3,036 | $416.02 | 13.7% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 11 | 11 | $1,485 | $315.15 | 21.2% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 16 | 16 | $1,120 | $307.36 | 27.4% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 25 | 25 | $1,350 | $201.02 | 14.9% |
About Dr. Nizar Noureddine, M.D
Dr. Nizar Noureddine, M.D is a Cardiovascular Disease healthcare provider based in Winston Salem, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659334530.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nizar Noureddine, M.D has received a total of $62,885 in payments from pharmaceutical and medical device companies, with $1,189 received in 2024. These payments were reported across 717 transactions from 33 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($30,090).
As a Medicare-enrolled provider, Noureddine has provided services to 9,912 Medicare beneficiaries, totaling 10,918 services with total Medicare billing of $462,895. Data is available for 4 years (2020–2023), covering 130 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology, Internal Medicine
- Location Winston Salem, NC
- Active Since 04/10/2006
- Last Updated 01/26/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1659334530
Products in Payments
- Ranexa (Drug) $24,738
- ZONTIVITY (Drug) $16,066
- LifeVest (Device) $8,337
- Impella (Device) $1,896
- ENTRESTO (Drug) $1,706
- BRILINTA (Drug) $1,332
- DRAGONFLY OPSTAR (Device) $800.00
- Repatha (Biological) $766.81
- XARELTO (Drug) $695.15
- Barostim Neo System (Device) $653.37
- ELIQUIS (Drug) $572.52
- WATCHMAN (Device) $345.31
- Corlanor (Drug) $308.86
- JARDIANCE (Drug) $293.36
- WATCHMAN DEVICE (Device) $281.17
- LEQVIO (Drug) $252.08
- LOKELMA (Drug) $206.44
- (CK4) MCOT (Device) $189.21
- IGT D Coronary (Device) $168.80
- SYMPLICITY G3 (Device) $168.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Winston Salem
Dalane Kitzman, Md, MD
Cardiovascular Disease — Payments: $612,959
Cardiovascular Disease $612,959
Mark Mitchell, Md, MD
Cardiovascular Disease — Payments: $87,413
Cardiovascular Disease $87,413
Charles Harris, Md, MD
Cardiovascular Disease — Payments: $43,442
Cardiovascular Disease $43,442
Dr. Samuel Turner, M.d, M.D
Cardiovascular Disease — Payments: $42,986
Cardiovascular Disease $42,986
Michael Drucker, Md, MD
Cardiovascular Disease — Payments: $41,438
Cardiovascular Disease $41,438
Dr. Rafael Cavalcanti, M.d, M.D
Cardiovascular Disease — Payments: $33,643
Cardiovascular Disease $33,643